Global Single-Domain Antibody Platform Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 45687
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Single-Domain Antibody Platform market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Single-Domain Antibody Platform size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Single-Domain Antibody Platform market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Single-Domain Antibody Platform market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Multi-Specific Single Domain Antibody

Bispecific Single Domain Antibody

Multivalent Single Domain Antibody

Mono-Specific Single Domain Antibody

Market segment by Application, can be divided into

Diagnostic Laboratories

Clinical Laboratories

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Market segment by players, this report covers

Creative BioLabs A

Synbio Technologies

ProSci Incorporated

BioCat GmbH

Antibody Design Labs

GenScript

Oak BioSciences, Inc.

Rockland Immunochemicals, Inc

Hybrigenics Services

NeoClone Biotechnology International LLC

Kaneka Eurogentec S.A

ProteoGenix

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Single-Domain Antibody Platform

1.2 Classification of Single-Domain Antibody Platform by Type

1.2.1 Overview: Global Single-Domain Antibody Platform Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Single-Domain Antibody Platform Revenue Market Share by Type in 2020

1.2.3 Multi-Specific Single Domain Antibody

1.2.4 Bispecific Single Domain Antibody

1.2.5 Multivalent Single Domain Antibody

1.2.6 Mono-Specific Single Domain Antibody

1.3 Global Single-Domain Antibody Platform Market by Application

1.3.1 Overview: Global Single-Domain Antibody Platform Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Diagnostic Laboratories

1.3.3 Clinical Laboratories

1.3.4 Academic and Research Institutes

1.3.5 Pharmaceutical and Biotechnology Companies

1.4 Global Single-Domain Antibody Platform Market Size & Forecast

1.5 Global Single-Domain Antibody Platform Market Size and Forecast by Region

1.5.1 Global Single-Domain Antibody Platform Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Single-Domain Antibody Platform Market Size by Region, (2016-2021)

1.5.3 North America Single-Domain Antibody Platform Market Size and Prospect (2016-2026)

1.5.4 Europe Single-Domain Antibody Platform Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Single-Domain Antibody Platform Market Size and Prospect (2016-2026)

1.5.6 South America Single-Domain Antibody Platform Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Single-Domain Antibody Platform Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Single-Domain Antibody Platform Market Drivers

1.6.2 Single-Domain Antibody Platform Market Restraints

1.6.3 Single-Domain Antibody Platform Trends Analysis

2 Company Profiles

2.1 Creative BioLabs A

2.1.1 Creative BioLabs A Details

2.1.2 Creative BioLabs A Major Business

2.1.3 Creative BioLabs A Single-Domain Antibody Platform Product and Solutions

2.1.4 Creative BioLabs A Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Creative BioLabs A Recent Developments and Future Plans

2.2 Synbio Technologies

2.2.1 Synbio Technologies Details

2.2.2 Synbio Technologies Major Business

2.2.3 Synbio Technologies Single-Domain Antibody Platform Product and Solutions

2.2.4 Synbio Technologies Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Synbio Technologies Recent Developments and Future Plans

2.3 ProSci Incorporated

2.3.1 ProSci Incorporated Details

2.3.2 ProSci Incorporated Major Business

2.3.3 ProSci Incorporated Single-Domain Antibody Platform Product and Solutions

2.3.4 ProSci Incorporated Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 ProSci Incorporated Recent Developments and Future Plans

2.4 BioCat GmbH

2.4.1 BioCat GmbH Details

2.4.2 BioCat GmbH Major Business

2.4.3 BioCat GmbH Single-Domain Antibody Platform Product and Solutions

2.4.4 BioCat GmbH Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 BioCat GmbH Recent Developments and Future Plans

2.5 Antibody Design Labs

2.5.1 Antibody Design Labs Details

2.5.2 Antibody Design Labs Major Business

2.5.3 Antibody Design Labs Single-Domain Antibody Platform Product and Solutions

2.5.4 Antibody Design Labs Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Antibody Design Labs Recent Developments and Future Plans

2.6 GenScript

2.6.1 GenScript Details

2.6.2 GenScript Major Business

2.6.3 GenScript Single-Domain Antibody Platform Product and Solutions

2.6.4 GenScript Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 GenScript Recent Developments and Future Plans

2.7 Oak BioSciences, Inc.

2.7.1 Oak BioSciences, Inc. Details

2.7.2 Oak BioSciences, Inc. Major Business

2.7.3 Oak BioSciences, Inc. Single-Domain Antibody Platform Product and Solutions

2.7.4 Oak BioSciences, Inc. Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Oak BioSciences, Inc. Recent Developments and Future Plans

2.8 Rockland Immunochemicals, Inc

2.8.1 Rockland Immunochemicals, Inc Details

2.8.2 Rockland Immunochemicals, Inc Major Business

2.8.3 Rockland Immunochemicals, Inc Single-Domain Antibody Platform Product and Solutions

2.8.4 Rockland Immunochemicals, Inc Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Rockland Immunochemicals, Inc Recent Developments and Future Plans

2.9 Hybrigenics Services

2.9.1 Hybrigenics Services Details

2.9.2 Hybrigenics Services Major Business

2.9.3 Hybrigenics Services Single-Domain Antibody Platform Product and Solutions

2.9.4 Hybrigenics Services Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Hybrigenics Services Recent Developments and Future Plans

2.10 NeoClone Biotechnology International LLC

2.10.1 NeoClone Biotechnology International LLC Details

2.10.2 NeoClone Biotechnology International LLC Major Business

2.10.3 NeoClone Biotechnology International LLC Single-Domain Antibody Platform Product and Solutions

2.10.4 NeoClone Biotechnology International LLC Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 NeoClone Biotechnology International LLC Recent Developments and Future Plans

2.11 Kaneka Eurogentec S.A

2.11.1 Kaneka Eurogentec S.A Details

2.11.2 Kaneka Eurogentec S.A Major Business

2.11.3 Kaneka Eurogentec S.A Single-Domain Antibody Platform Product and Solutions

2.11.4 Kaneka Eurogentec S.A Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Kaneka Eurogentec S.A Recent Developments and Future Plans

2.12 ProteoGenix

2.12.1 ProteoGenix Details

2.12.2 ProteoGenix Major Business

2.12.3 ProteoGenix Single-Domain Antibody Platform Product and Solutions

2.12.4 ProteoGenix Single-Domain Antibody Platform Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 ProteoGenix Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Single-Domain Antibody Platform Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Single-Domain Antibody Platform Players Market Share

3.2.2 Top 10 Single-Domain Antibody Platform Players Market Share

3.2.3 Market Competition Trend

3.3 Single-Domain Antibody Platform Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Single-Domain Antibody Platform Revenue and Market Share by Type (2016-2021)

4.2 Global Single-Domain Antibody Platform Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Single-Domain Antibody Platform Revenue Market Share by Application (2016-2021)

5.2 Single-Domain Antibody Platform Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Single-Domain Antibody Platform Revenue by Type (2016-2026)

6.2 North America Single-Domain Antibody Platform Revenue by Application (2016-2026)

6.3 North America Single-Domain Antibody Platform Market Size by Country

6.3.1 North America Single-Domain Antibody Platform Revenue by Country (2016-2026)

6.3.2 United States Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

6.3.3 Canada Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

6.3.4 Mexico Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Single-Domain Antibody Platform Revenue by Type (2016-2026)

7.2 Europe Single-Domain Antibody Platform Revenue by Application (2016-2026)

7.3 Europe Single-Domain Antibody Platform Market Size by Country

7.3.1 Europe Single-Domain Antibody Platform Revenue by Country (2016-2026)

7.3.2 Germany Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

7.3.3 France Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

7.3.5 Russia Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

7.3.6 Italy Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Single-Domain Antibody Platform Revenue by Type (2016-2026)

8.2 Asia-Pacific Single-Domain Antibody Platform Revenue by Application (2016-2026)

8.3 Asia-Pacific Single-Domain Antibody Platform Market Size by Region

8.3.1 Asia-Pacific Single-Domain Antibody Platform Revenue by Region (2016-2026)

8.3.2 China Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

8.3.3 Japan Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

8.3.4 South Korea Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

8.3.5 India Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

8.3.7 Australia Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Single-Domain Antibody Platform Revenue by Type (2016-2026)

9.2 South America Single-Domain Antibody Platform Revenue by Application (2016-2026)

9.3 South America Single-Domain Antibody Platform Market Size by Country

9.3.1 South America Single-Domain Antibody Platform Revenue by Country (2016-2026)

9.3.2 Brazil Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

9.3.3 Argentina Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Single-Domain Antibody Platform Revenue by Type (2016-2026)

10.2 Middle East & Africa Single-Domain Antibody Platform Revenue by Application (2016-2026)

10.3 Middle East & Africa Single-Domain Antibody Platform Market Size by Country

10.3.1 Middle East & Africa Single-Domain Antibody Platform Revenue by Country (2016-2026)

10.3.2 Turkey Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

10.3.4 UAE Single-Domain Antibody Platform Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Single-Domain Antibody Platform Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Single-Domain Antibody Platform Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Single-Domain Antibody Platform Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Single-Domain Antibody Platform Revenue (USD Million) by Region (2016-2021)

Table 5. Global Single-Domain Antibody Platform Revenue Market Share by Region (2021-2026)

Table 6. Creative BioLabs A Corporate Information, Head Office, and Major Competitors

Table 7. Creative BioLabs A Major Business

Table 8. Creative BioLabs A Single-Domain Antibody Platform Product and Solutions

Table 9. Creative BioLabs A Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Synbio Technologies Corporate Information, Head Office, and Major Competitors

Table 11. Synbio Technologies Major Business

Table 12. Synbio Technologies Single-Domain Antibody Platform Product and Solutions

Table 13. Synbio Technologies Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. ProSci Incorporated Corporate Information, Head Office, and Major Competitors

Table 15. ProSci Incorporated Major Business

Table 16. ProSci Incorporated Single-Domain Antibody Platform Product and Solutions

Table 17. ProSci Incorporated Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. BioCat GmbH Corporate Information, Head Office, and Major Competitors

Table 19. BioCat GmbH Major Business

Table 20. BioCat GmbH Single-Domain Antibody Platform Product and Solutions

Table 21. BioCat GmbH Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Antibody Design Labs Corporate Information, Head Office, and Major Competitors

Table 23. Antibody Design Labs Major Business

Table 24. Antibody Design Labs Single-Domain Antibody Platform Product and Solutions

Table 25. Antibody Design Labs Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. GenScript Corporate Information, Head Office, and Major Competitors

Table 27. GenScript Major Business

Table 28. GenScript Single-Domain Antibody Platform Product and Solutions

Table 29. GenScript Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Oak BioSciences, Inc. Corporate Information, Head Office, and Major Competitors

Table 31. Oak BioSciences, Inc. Major Business

Table 32. Oak BioSciences, Inc. Single-Domain Antibody Platform Product and Solutions

Table 33. Oak BioSciences, Inc. Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Rockland Immunochemicals, Inc Corporate Information, Head Office, and Major Competitors

Table 35. Rockland Immunochemicals, Inc Major Business

Table 36. Rockland Immunochemicals, Inc Single-Domain Antibody Platform Product and Solutions

Table 37. Rockland Immunochemicals, Inc Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Hybrigenics Services Corporate Information, Head Office, and Major Competitors

Table 39. Hybrigenics Services Major Business

Table 40. Hybrigenics Services Single-Domain Antibody Platform Product and Solutions

Table 41. Hybrigenics Services Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. NeoClone Biotechnology International LLC Corporate Information, Head Office, and Major Competitors

Table 43. NeoClone Biotechnology International LLC Major Business

Table 44. NeoClone Biotechnology International LLC Single-Domain Antibody Platform Product and Solutions

Table 45. NeoClone Biotechnology International LLC Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Kaneka Eurogentec S.A Corporate Information, Head Office, and Major Competitors

Table 47. Kaneka Eurogentec S.A Major Business

Table 48. Kaneka Eurogentec S.A Single-Domain Antibody Platform Product and Solutions

Table 49. Kaneka Eurogentec S.A Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. ProteoGenix Corporate Information, Head Office, and Major Competitors

Table 51. ProteoGenix Major Business

Table 52. ProteoGenix Single-Domain Antibody Platform Product and Solutions

Table 53. ProteoGenix Single-Domain Antibody Platform Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Global Single-Domain Antibody Platform Revenue (USD Million) by Players (2019-2021)

Table 55. Global Single-Domain Antibody Platform Revenue Share by Players (2019-2021)

Table 56. Breakdown of Single-Domain Antibody Platform by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Single-Domain Antibody Platform Players Head Office, Products and Services Provided

Table 58. Single-Domain Antibody Platform Mergers & Acquisitions in the Past Five Years

Table 59. Single-Domain Antibody Platform New Entrants and Expansion Plans

Table 60. Global Single-Domain Antibody Platform Revenue (USD Million) by Type (2016-2021)

Table 61. Global Single-Domain Antibody Platform Revenue Share by Type (2016-2021)

Table 62. Global Single-Domain Antibody Platform Revenue Forecast by Type (2021-2026)

Table 63. Global Single-Domain Antibody Platform Revenue by Application (2016-2021)

Table 64. Global Single-Domain Antibody Platform Revenue Forecast by Application (2021-2026)

Table 65. North America Single-Domain Antibody Platform Revenue by Type (2016-2021) & (USD Million)

Table 66. North America Single-Domain Antibody Platform Revenue by Type (2021-2026) & (USD Million)

Table 67. North America Single-Domain Antibody Platform Revenue by Application (2016-2021) & (USD Million)

Table 68. North America Single-Domain Antibody Platform Revenue by Application (2021-2026) & (USD Million)

Table 69. North America Single-Domain Antibody Platform Revenue by Country (2016-2021) & (USD Million)

Table 70. North America Single-Domain Antibody Platform Revenue by Country (2021-2026) & (USD Million)

Table 71. Europe Single-Domain Antibody Platform Revenue by Type (2016-2021) & (USD Million)

Table 72. Europe Single-Domain Antibody Platform Revenue by Type (2021-2026) & (USD Million)

Table 73. Europe Single-Domain Antibody Platform Revenue by Application (2016-2021) & (USD Million)

Table 74. Europe Single-Domain Antibody Platform Revenue by Application (2021-2026) & (USD Million)

Table 75. Europe Single-Domain Antibody Platform Revenue by Country (2016-2021) & (USD Million)

Table 76. Europe Single-Domain Antibody Platform Revenue by Country (2021-2026) & (USD Million)

Table 77. Asia-Pacific Single-Domain Antibody Platform Revenue by Type (2016-2021) & (USD Million)

Table 78. Asia-Pacific Single-Domain Antibody Platform Revenue by Type (2021-2026) & (USD Million)

Table 79. Asia-Pacific Single-Domain Antibody Platform Revenue by Application (2016-2021) & (USD Million)

Table 80. Asia-Pacific Single-Domain Antibody Platform Revenue by Application (2021-2026) & (USD Million)

Table 81. Asia-Pacific Single-Domain Antibody Platform Revenue by Region (2016-2021) & (USD Million)

Table 82. Asia-Pacific Single-Domain Antibody Platform Revenue by Region (2021-2026) & (USD Million)

Table 83. South America Single-Domain Antibody Platform Revenue by Type (2016-2021) & (USD Million)

Table 84. South America Single-Domain Antibody Platform Revenue by Type (2021-2026) & (USD Million)

Table 85. South America Single-Domain Antibody Platform Revenue by Application (2016-2021) & (USD Million)

Table 86. South America Single-Domain Antibody Platform Revenue by Application (2021-2026) & (USD Million)

Table 87. South America Single-Domain Antibody Platform Revenue by Country (2016-2021) & (USD Million)

Table 88. South America Single-Domain Antibody Platform Revenue by Country (2021-2026) & (USD Million)

Table 89. Middle East & Africa Single-Domain Antibody Platform Revenue by Type (2016-2021) & (USD Million)

Table 90. Middle East & Africa Single-Domain Antibody Platform Revenue by Type (2021-2026) & (USD Million)

Table 91. Middle East & Africa Single-Domain Antibody Platform Revenue by Application (2016-2021) & (USD Million)

Table 92. Middle East & Africa Single-Domain Antibody Platform Revenue by Application (2021-2026) & (USD Million)

Table 93. Middle East & Africa Single-Domain Antibody Platform Revenue by Country (2016-2021) & (USD Million)

Table 94. Middle East & Africa Single-Domain Antibody Platform Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Single-Domain Antibody Platform Picture

Figure 2. Global Single-Domain Antibody Platform Revenue Market Share by Type in 2020

Figure 3. Multi-Specific Single Domain Antibody

Figure 4. Bispecific Single Domain Antibody

Figure 5. Multivalent Single Domain Antibody

Figure 6. Mono-Specific Single Domain Antibody

Figure 7. Single-Domain Antibody Platform Revenue Market Share by Application in 2020

Figure 8. Diagnostic Laboratories Picture

Figure 9. Clinical Laboratories Picture

Figure 10. Academic and Research Institutes Picture

Figure 11. Pharmaceutical and Biotechnology Companies Picture

Figure 12. Global Single-Domain Antibody Platform Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Single-Domain Antibody Platform Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Single-Domain Antibody Platform Revenue Market Share by Region (2016-2026)

Figure 15. Global Single-Domain Antibody Platform Revenue Market Share by Region in 2020

Figure 16. North America Single-Domain Antibody Platform Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Single-Domain Antibody Platform Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Single-Domain Antibody Platform Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Single-Domain Antibody Platform Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Single-Domain Antibody Platform Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Single-Domain Antibody Platform Market Drivers

Figure 22. Single-Domain Antibody Platform Market Restraints

Figure 23. Single-Domain Antibody Platform Market Trends

Figure 24. Creative BioLabs A Recent Developments and Future Plans

Figure 25. Synbio Technologies Recent Developments and Future Plans

Figure 26. ProSci Incorporated Recent Developments and Future Plans

Figure 27. BioCat GmbH Recent Developments and Future Plans

Figure 28. Antibody Design Labs Recent Developments and Future Plans

Figure 29. GenScript Recent Developments and Future Plans

Figure 30. Oak BioSciences, Inc. Recent Developments and Future Plans

Figure 31. Rockland Immunochemicals, Inc Recent Developments and Future Plans

Figure 32. Hybrigenics Services Recent Developments and Future Plans

Figure 33. NeoClone Biotechnology International LLC Recent Developments and Future Plans

Figure 34. Kaneka Eurogentec S.A Recent Developments and Future Plans

Figure 35. ProteoGenix Recent Developments and Future Plans

Figure 36. Global Single-Domain Antibody Platform Revenue Share by Players in 2020

Figure 37. Single-Domain Antibody Platform Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Single-Domain Antibody Platform Revenue Market Share in 2020

Figure 39. Global Top 10 Players Single-Domain Antibody Platform Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Single-Domain Antibody Platform Revenue Share by Type in 2020

Figure 42. Global Single-Domain Antibody Platform Market Share Forecast by Type (2021-2026)

Figure 43. Global Single-Domain Antibody Platform Revenue Share by Application in 2020

Figure 44. Global Single-Domain Antibody Platform Market Share Forecast by Application (2021-2026)

Figure 45. North America Single-Domain Antibody Platform Sales Market Share by Type (2016-2026)

Figure 46. North America Single-Domain Antibody Platform Sales Market Share by Application (2016-2026)

Figure 47. North America Single-Domain Antibody Platform Revenue Market Share by Country (2016-2026)

Figure 48. United States Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Single-Domain Antibody Platform Sales Market Share by Type (2016-2026)

Figure 52. Europe Single-Domain Antibody Platform Sales Market Share by Application (2016-2026)

Figure 53. Europe Single-Domain Antibody Platform Revenue Market Share by Country (2016-2026)

Figure 54. Germany Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Single-Domain Antibody Platform Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Single-Domain Antibody Platform Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Single-Domain Antibody Platform Revenue Market Share by Region (2016-2026)

Figure 62. China Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Single-Domain Antibody Platform Sales Market Share by Type (2016-2026)

Figure 69. South America Single-Domain Antibody Platform Sales Market Share by Application (2016-2026)

Figure 70. South America Single-Domain Antibody Platform Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Single-Domain Antibody Platform Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Single-Domain Antibody Platform Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Single-Domain Antibody Platform Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Single-Domain Antibody Platform Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source